blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2886113

EP2886113 - Ophthalmic composition for the correction of presbyopia [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.07.2020
Database last updated on 11.09.2024
FormerExamination is in progress
Status updated on  15.12.2017
Most recent event   Tooltip03.07.2020Application deemed to be withdrawnpublished on 05.08.2020  [2020/32]
Applicant(s)For all designated states
Eurocanarias Oftalmologica, S.L.
C/Leon y Castillo, 211
35004 Las Palmas de Gran Canarias / ES
[2015/26]
Inventor(s)01 / Rodriguez Hernandez, Vincente
c/león y Castillo 211
35004 Las Palmas de Gran Canarias / ES
02 / Carreras Diaz, Humberto
c/león y Castillo 211
35004 Las Palmas de Gran Canarias / ES
 [2015/26]
Representative(s)Monni, Richard, et al
Cabinet LLR
11 boulevard de Sébastopol
75001 Paris / FR
[N/P]
Former [2015/26]Jeannet, Olivier
JEANNET & Associés
26 Quai Claude Bernard
69007 Lyon / FR
Application number, filing date14169660.923.05.2014
[2015/26]
Priority number, dateES2013000117720.12.2013         Original published format: ES 201301177
[2015/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2886113
Date:24.06.2015
Language:EN
[2015/26]
Search report(s)(Supplementary) European search report - dispatched on:EP08.05.2015
ClassificationIPC:A61K31/196, A61K31/4178, A61P27/02
[2015/26]
CPC:
A61K31/4178 (EP,US); A61K31/196 (EP,US); A61K9/0048 (US);
A61P27/02 (EP); A61P27/10 (EP); A61P43/00 (EP)
C-Set:
A61K31/196, A61K2300/00 (US,EP);
A61K31/4178, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/04]
Former [2015/26]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBANot yet paid
MENot yet paid
TitleGerman:Ophthalmische Zusammensetzung zur Korrektur von Presbyopie[2015/26]
English:Ophthalmic composition for the correction of presbyopia[2015/26]
French:Composition ophtalmique pour la correction de la presbytie[2015/26]
Examination procedure21.12.2015Examination requested  [2016/04]
18.12.2017Despatch of a communication from the examining division (Time limit: M04)
28.03.2018Reply to a communication from the examining division
07.03.2019Observations by third parties
25.07.2019Cancellation of oral proceeding that was planned for 19.09.2019
19.09.2019Date of oral proceedings (cancelled)
03.12.2019Application deemed to be withdrawn, date of legal effect  [2020/32]
07.01.2020Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2020/32]
Fees paidRenewal fee
11.04.2016Renewal fee patent year 03
23.05.2017Renewal fee patent year 04
31.05.2018Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.201906   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]WO2008075149  (BENOZZI JORGE LUIS [AR]) [I] 1-9 * page 2, lines 9-20 * * page 4, line 18 - page 5, line 6 * * page 6, line 10 * * claims 1-3 *;
 [Y]WO2013041967  (ALTAVISTA INST DE INVEST MEDICA S A S [CO]) [Y] 1-9 * page 3, line 24 - page 4, line 2 * * example 5 *;
 [Y]  - BONNIE A HENDERSON ET AL, "Safety and Efficacy of Bromfenac Ophthalmic Solution () Dosed Once Daily for Postoperative Ocular Inflammation and Pain", OPHTHALMOLOGY, J. B. LIPPINCOTT CO., PHILADELPHIA, PA, US, vol. 118, no. 11, doi:10.1016/J.OPHTHA.2011.04.035, ISSN 0161-6420, (20110427), pages 2120 - 2127, (20110504), XP028332685 [Y] 1-9 * page 2120, column 2, paragraph l - page 2121, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/j.ophtha.2011.04.035
 [A]  - L. DAVID WATERBURY ET AL, "Ocular Penetration and Anti-inflammatory Activity of Ketorolac 0.45% and Bromfenac 0.09% Against Lipopolysaccharide-Induced Inflammation", JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, (20110225), vol. 27, no. 2, doi:10.1089/jop.2010.0135, ISSN 1080-7683, pages 173 - 178, XP055186089 [A] 1-9 * abstract * * page 173, column 2, lines 5-7 *

DOI:   http://dx.doi.org/10.1089/jop.2010.0135
 [A]  - JANITA P.C. CHAU ET AL, "A Systematic Review of Methods of Eye Irrigation for Adults and Children with Ocular Chemical Burns", WORLDVIEWS ON EVIDENCE-BASED NURSING, (20110607), vol. 9, no. 3, doi:10.1111/j.1741-6787.2011.00220.x, ISSN 1545-102X, pages 129 - 138, XP055186066 [A] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1111/j.1741-6787.2011.00220.x
 [A]  - FRANCISCO ETCHABERRY, "Colirio de suero autólogo", OFFARM, (200707), vol. 26, no. 7, pages 100 - 105, XP055186068 [A] 1-9 * page 100, column 2, paragraphs 4-5 *
 [A]  - MAGDALENA W ET AL, "New methods of treatment in presbyopia", ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE 2010 WROCLAW UNIVERSITY OF MEDICINE POL, (201005), vol. 19, no. 3, ISSN 1230-025X, pages 405 - 409, XP055186091 [A] 1-9 * the whole document *
by applicantES2228153T
 ES2304824
 ES2337748
 ES2342684T
 ES2351515T
otherUS2013096199
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.